ASX - Delayed Quote AUD
Clinuvel Pharmaceuticals Limited (CUV.AX)
10.71
-0.12
(-1.11%)
At close: 4:10:21 PM GMT+10
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 8.6M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Shanahan (Brenda Mary) Former | -- | Direct | -- | Oct 16, 2024 |
| Agersborg (Karen) Director (Non-Executive) | Other at price 10.55 per share. | Direct | 60,458 | Oct 3, 2024 |
| Keamy (Darren M) Chief Financial Officer | -- | Direct | -- | Jun 30, 2024 |
| Wright (Dennis J) Divisional Officer | -- | Direct | -- | Jun 30, 2024 |
| Wolgen (Philippe Jacques) Chief Executive Officer | -- | Direct | -- | Nov 24, 2023 |
| Wolgen (Philippe Jacques) Chief Executive Officer | Purchase at price 10.40 per share. | Direct | 19,241 | Sep 19, 2023 |
| Keamy (Darren M) Chief Financial Officer | -- | Direct | -- | Aug 15, 2023 |
| Wright (Dennis J) Divisional Officer | -- | Direct | -- | Aug 15, 2023 |
| Wolgen (Philippe Jacques) Chief Executive Officer | Purchase at price 11.69 per share. | Direct | 25,741,392 | Jun 28, 2023 |
Related Tickers
MSB.AX Mesoblast Limited
1.7300
-3.89%
SPAGO.ST Spago Nanomedical AB (publ)
0.1910
+1.60%
PYPB.SG IXICO PLC
0.1020
+9.09%
ZLD.AX Zelira Therapeutics Limited
0.4000
-13.04%
REGN34.SA Regeneron Pharmaceuticals, Inc.
53.31
0.00%
CU6.AX Clarity Pharmaceuticals Ltd
2.5000
-0.79%
2CUREX.ST 2cureX AB (publ)
1.7750
-9.90%
RCE.AX Recce Pharmaceuticals Ltd
0.2900
-1.69%
LTP.AX LTR PHARMA FPO [LTP]
0.3050
-1.61%
NEU.AX Neuren Pharmaceuticals Limited
13.19
+1.77%